Western Blotting Market
Number of pages: 100 | Report Format: PDF | Published date: October 31, 2022
Historical Years – 2020 | Base Year – 2021 | Forecasted Years – 2022-2030
|
Report Attribute |
Details |
|
Market size value in 2021 |
US$ 1.2 billion |
|
Revenue forecast in 2030 |
US$ 2.18 billion |
|
Growth Rate |
CAGR of 6.9% from 2022 to 2030 |
|
Base year for estimation |
2021 |
|
Forecast period |
2022-2030 |
|
Segments covered |
By Product, Application, End User and Region. |
|
Regional scope |
North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
The global western blotting market was pegged at US$ 1.2 billion in 2021 and is expected to witness a CAGR of 6.9% during the forecast period.
Market Fundamental
One of the most important methods in cell and molecular biology is called western blotting, commonly known as protein blotting and immunoblotting. Using this method, it is possible to determine whether a specific protein is present in a complex cell-extracted solution. Western blotting is frequently used to validate gene expression, show antibody specificity, establish medical diagnoses, and find post-translational changes. Using gel electrophoresis, proteins are sorted according to their molecular weight. The basic steps in western blotting are tissue preparation, gel electrophoresis, protein transfer to membrane, blocking to avoid membrane and antibody interactions, membrane incubation, and antibody-based protein detection.
[8978923]
Market Dynamic
The market for western blotting is expanding as HIV cases around the world rise. Other significant factors boosting the growth of the global western blotting market are the rapidly expanding uses of this technique in the field of proteomics and increased efforts and investments by various pharmaceutical and biotechnology companies in research and development. The primary obstacles to this technology's development include, however, pricey equipment, high primary antibody prices, time constraints, the advent of substitute technologies, and the need for specialised workers in equipment handling.
Market Ecosystem
The global western blotting market has been analysed from four perspectives by product, application, end user and region.
Western Blotting Market by Product
Based on product, the global western blotting market has been segmented into consumables and instruments. The consumables segment is sub segmented into reagents and kits whereas the instrument segment has sub segmented into gel electrophoresis instrument, blotting system, imagers. The blotting system is also sub segmented into semi-dry blotting system and wet blotting system whereas imagers are also categorized into chemiluminescent, fluorescent and others. The consumables segment dominated the market during forecast period. The frequent usage of consumables and the extensive use of reagents in the western blotting procedure are the main causes of this product segment's high market share.
Western Blotting Market by Application
[23217893]
Based on application, the global western blotting market has been segmented into biomedical and biochemical research, disease diagnosis, and agriculture. The biomedical and biochemical segment dominated the global western blotting market during the forecast period. The significant market share is attributed to rising research spending on proteomics and protein-based studies as well as rising research efforts by end users including biopharma and biotech companies.
Western Blotting Market by End User
Based on end user, the global western blotting market has been segmented into academic & research institutes, biopharma and biotechnology companies, and hospitals & diagnostics laboratories and others. The academic & research institutes dominated the segment during forecast period. The significant proportion of academic and research activity and the growth of proteomics-related research.
Western Blotting Market by Region
Based on region, the global western blotting market has been segmented into North America, Europe, Asia Pacific, Rest of the World. In terms of the regional markets, North America stood out as the market with the largest income share for western blotting. The presence of an advanced healthcare system, rising investments in proteomics research, and growing attention to personalised therapy and genetically modified crops are the key causes of revenue growth in the North American market. Due to the presence of major industry players in the region, the western blotting market in North America is anticipated to experience strong revenue growth throughout the forecast period.
The Asia-Pacific western blotting market is anticipated to post the fastest revenue CAGR. Major factors influencing the growth of the APAC market include rising population, a thriving healthcare sector, and technological advancement in the countries in the area. The development of the APAC market is also being aided by the existence of bio clusters in China, Japan, and India, rising funding for life science research, and expanding initiatives aimed at advancing disease diagnostics.
Competitive Landscape
Some of the prominent market player in the global western blotting market include
Strategic Development
Western blotting has been increasingly popular in cancer R&D. For instance, western blotting was reportedly utilised in January 2020 by researchers at The First Affiliated Hospital of Soochow University in China to examine the role of microRNA-708 (miR-708) in cervical cancer.
Some of the prominent market player in the global western blotting market include, PerkinElmer, Abcam plc, Thermo Fisher Scientific, Stressmarq Biosciences, Li-Cor and others.
The biomedical and biochemical segment dominated the segment during forecast period.
The Asia Pacific region dominated the market during forecast period.
The emergence of alternative technologies is predicted to hinder market expansion. In the detection of biomolecules, for instance, AlphaScreen technology is a new and very sensitive homogeneous bead-based platform. The method, which identifies any molecule of interest, mostly from protein complexes, does not require the time-consuming wash-steps.
*Insights on financial performance is subject to availability of information in public domain